Theriva Biologics, Inc. — Form D
Theriva Biologics, Inc. of ROCKVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2022-08-04. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-08-04
- Form: D
- Accession: 0001104659-22-085738
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Minimum investment: $3.0M
- Investors: 1
- Date of first sale: 2022-07-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-454779
Issuer
- Name: Theriva Biologics, Inc.
- CIK: 0000894158
- Entity type: Corporation
- Jurisdiction: NEVADA
- Address: 9605 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
- Phone: 301-417-4364
Officers, directors & promoters (20)
| Name | Role | Location |
|---|
| Jeffrey J Wolf | Director | Rockville, MD |
| Jeffrey J Kraws | Director | Rockville, MD |
| Jeffrey A Wolf | Director | Rockville, MD |
| John J Monahan | Director | Rockville, MD |
| Jeffrey Riley | Director | Nampa, ID |
| Jeffrey Riley | Executive Officer | Nampa, ID |
| Steven A Shallcross | Director | Rockville, MD |
| Steven A Shallcross | Executive Officer | Rockville, MD |
| C. Evan Ballantyne | Executive Officer | New Hope, PA |
| Jeffrey Kraws | Director | Carlsbad, CA |
| Scott Tarriff | Director | Rockville, MD |
| Joseph Sliman | Executive Officer | Rockville, MD |
| Jeffrey Wolf | Director | Rockville, MD |
| Steven Shallcross | Executive Officer | Rockville, MD |
| Jeffrey Evan Kraws | Director | Ann Arbor, MI |
| Jeffrey Evan Wolf | Director | Ann Arbor, MI |
| Scott Evan Tarriff | Director | Ann Arbor, MI |
| Steve Evan Kanzer | Director | Ann Arbor, MI |
| Scott L Tarriff | Director | Ann Arbor, MI |
| Steve H Kanzer | Director | Ann Arbor, MI |
Other filings by this issuer (5)
More